Skip to content
  • Home
  • IOncology
  • Infectious Desease Frontier
  • IHepatology
  • Hematology Frontier
  • Conference topics
  • Experts Interviews
  • Informations
  • Live Broadcasting
  • Logout
MediaMedic

Connecting Medical Expertise through Media

  • Home
  • IOncology
  • Infectious Disease Frontier
  • International Hepatology
  • Hematology Frontier
  • Conference topics
  • Experts’ Interviews
  • Informations
  • Home
  • IOncology
  • Infectious Disease Frontier
  • International Hepatology
  • Hematology Frontier
  • Conference topics
  • Experts’ Interviews
  • Informations

#BladderCancer

Home » #BladderCancer
Unveiling Progress in Immunotherapy and Pathological Diagnosis for Urological Cancers: Insights from Dr. Félix Guerrero Ramos and Dr. Xuefeng Qiu at EAU Congress 2024

Unveiling Progress in Immunotherapy and Pathological Diagnosis for Urological Cancers: Insights from Dr. Félix Guerrero Ramos and Dr. Xuefeng Qiu at EAU Congress 2024

Posted by By Mourabit Halima 2024.05.09
In a significant gathering at the European Association of Urology (EAU) Congress 2024, held in the vibrant city of Paris, two esteemed figures in the field of urology, Dr. Félix…
Read More
EAU24 Interview | Dr. Jens Bedke:Innovations in Advanced Urothelial Carcinoma Treatment

EAU24 Interview | Dr. Jens Bedke:Innovations in Advanced Urothelial Carcinoma Treatment

Posted by By Mourabit Halima 2024.04.29
Editor's note: Platinum-based chemotherapy remains the cornerstone of treatment for advanced urothelial cancer (UC), but it still does not meet the long-term survival needs of patients; the 39th European Association…
Read More
ESMO Highlights | Professor Wei Yu’s Commentary on Advances in Neoadjuvant Therapy and Bladder Preservation in Bladder Cancer

ESMO Highlights | Professor Wei Yu’s Commentary on Advances in Neoadjuvant Therapy and Bladder Preservation in Bladder Cancer

Posted by By Lisa Cui 2024.01.19
Editor's Note: Bladder cancer is a common tumor in the urinary system, with muscle-invasive bladder cancer (MIBC) accounting for approximately 20% of all bladder cancers. Nearly half of non-muscle-invasive bladder…
Read More
Recent Posts
  • Highlights from the 13th International Conference of the Federation of Asian Clinical Oncology (FACO 2025)
  • ESMO China Voice | Professor Jiesong Wang: The iPET-NCCN-IPI Model May Optimize Risk Stratification in Diffuse Large B-Cell Lymphoma
  • ESMO China Voice | Dr. Sicong Zhang: Refractory DLBCL Patients Share Similar Immune Signatures
  • ESMO China Voice | Dr. Cong Sun: Grade 3B Follicular Lymphoma Is an Independent Risk Factor Affecting Both PFS and OS
  • ESMO China Voice | Prof. Liang Wang: CD19/CD22 Bispecific CAR-T Therapy Demonstrates Remarkable Efficacy and Safety in R/R LBCL
Recent Comments
    Archives
    • October 2025
    • September 2025
    • August 2025
    • July 2025
    • June 2025
    • May 2025
    • April 2025
    • March 2025
    • February 2025
    • January 2025
    • December 2024
    • November 2024
    • October 2024
    • September 2024
    • August 2024
    • July 2024
    • June 2024
    • May 2024
    • April 2024
    • March 2024
    • February 2024
    • January 2024
    • December 2023
    • November 2023
    • October 2023
    • August 2023
    Categories
    • Artificial intelligence
    • Hematology Frontier
    • Infectious Disease Frontier
    • International Hepatology
    • IOncology
    • Live broadcasting
    • Uncategorized
    • UroStream
    • LinkedIn
    • Twitter
    • Mail
    Related Media:
    Copyright 2025 — MediaMedic. All rights reserved. Blogun WordPress Theme
    Media Medic Publishing Company Limited(HK)
    赛美出版有限公司(香港)
    Scroll to Top